Track topics on Twitter Track topics that are important to you
TORONTO, ONTARIO -- (Marketwired) -- 02/28/17 -- Nutritional High International Inc. ("Nutritional High") (CSE: EAT)(CSE: EAT.CN)(OTCQB: SPLIF)(FRANKFURT: 2NU) and Lakeside Minerals Inc. ("Lakeside") (NEX: LAK.H) (together the "Companies" or the "Parties") are pleased to announce that they have entered into a Letter of Intent (the "Letter of Intent") dated February 22, 2017, whereby Lakeside will build medical and adult use cannabis cultivation facilities in Nevada and Colorado ("Proposed Transaction"), in accordance with applicable state law.
Description of the Proposed Transaction and the Target Assets
As a part of the Proposed Transaction, Lakeside will enter into the following arrangements with Nutritional High:
NH is under the contract to purchase the Nevada Cultivation License, from a third party ("Vendor") located in Nevada for US$500,000. The Vendor acquired the Nevada Cultivation License it in a competitive process and has not yet generated revenue. Further information regarding the expected build-out costs is being developed and will be available in due course. Please see below for details of the financial terms for Nevada JV and Colorado JV.
Strategic Vision for Lakeside
Starting with Nevada and Colorado, Lakeside will take steps to acquire or establish cannabis cultivation operations throughout US states which permit medical and adult use cannabis. Lakeside's cultivation facilities will be designed to utilize automation and technology and data collection and analysis to produce high quality cannabis in an efficient, safe and low cost manner. Building on the collective experience of Lakeside's board and executive team, Lakeside is expected to build or acquire, own, and operate highly effective, low cost cultivation facilities. Lakeside is currently engaging in discussions with various technology providers and developers to acquire, integrate and utilize best of breed automation systems and technology for these purposes.
Billy Morrison, Director and Officer of Nutritional High commented: "The leading cultivators in Canada, Holland, Israel and the US have demonstrated that analytics play a critical role in cannabis production. The collection and analysis of data will allow Lakeside to perfect growing processes, maintain high compliance standards and develop superior logistics channels for the express purpose of building patient and customer trust in the Lakeside brands."
Lakeside will begin designing a facility in Colorado to be operated by Palo Verde, LLC, a Colorado State Licensee. The Colorado facility will be designed to allow for parallel testing of the technology solutions as medical and adult use cannabis is grown commercially, building on a scientific approach to planned variances and control batches. Lakeside will implement these solutions in the proposed larger Nevada facility as the next step. Once its cultivation processes are validated and scaled, Lakeside may consider implementing a tissue culture ("TC") lab to underpin and further enhance and standardize the phenotypes in its cultivation processes. TC is a technique widely used in other branches of industrial scale agriculture to produce clones of a plant in a method known as micro propagation. TC rapidly multiplies the infant plant grow tissue giving rise to enhanced predictability of growth behavior and significant scalability. Lakeside will also consider implementing a licensing model to further increase its market penetration and share.
Robert Schwartz, Director of Lakeside commented: "We are going to use and add value to optimized cannabis cultivation technologies to build smart grows that will ensure Lakeside can be profitable and scaleable in an environment where cannabis growing will increasingly be commoditized. We will also develop distribution channels within each of the states to further improve the margins and accelerate growth. Colorado and Nevada are the initial two states where Lakeside aims to demonstrate its proof of concept, but will also pursue an aggressive expansion strategy in other Cole Memo compliant jurisdictions."
Lakeside will undertake a change of business ("COB"), which such transaction shall be subject to approval of its shareholders and the TSX Venture Exchange.
Contemplated Lakeside Financings
To fund its business plan, Lakeside intends to undertake a convertible debenture ("Debenture") private placement financing ("CD Offering") for gross proceeds of up to CAD $2,000,000. The Debenture shall be convertible into common shares in the capital of Lakeside ("Lakeside Shares"), at a price of no less than 25% discount to the Equity Financing Price (as defined below).
After completing the CD Offering Lakeside also intends to complete an equity financing ("Equity Financing") of up to 23,333,333 units of Lakeside (the "Units") at a price of C$0.30 per Unit (or such other price as may be agreed) for aggregate gross proceeds of up to C$7,000,000. Each Unit will consist of one common share of Lakeside (a "Common Share") and one-half of one common share purchase warrant (each whole warrant, a "Warrant"). It is expected that each Warrant will entitle the holder to purchase one Common Share at a price of C$0.45 per Common Share for a period of 18 months from the closing date.
All securities issued in connection with the CD Offering and the Equity Financing will be subject to a four-month hold from the date of issuance in accordance with applicable securities laws. The closing of the Offering is subject to receipt of approvals of the TSX Venture Exchange and other applicable securities regulatory authorities.
The net proceeds from the CD Offering and the Equity Financing will be used by Lakeside to build legal cannabis cultivation facilities in Nevada and Colorado, product development, research and development, and funding the costs relating to the COB and general working capital.
Strategic vision of Nutritional High
Nutritional High considers the proposed transaction with Lakeside as a strategic opportunity to ensure Nutritional High will be able to continue to focus all of its resources on the oils and edibles segment of the marijuana market. While growing marijuana can be a lucrative endeavour, such effort takes focus and capital. With the increasingly vast opportunities for oils and edibles in the US, Nutritional High is pleased to continue its focus in that segment while working with Lakeside as a partner which will focus on excellence and innovation in cannabis cultivation.
This arrangement will allow both Lakeside and Nutritional High to bifurcate the economics of the future integrated cultivation/extraction operations as they present themselves by matching the projects with the appropriate management teams and shareholder base. Sharing the capital cost would also augment the economics for Nutritional High.
In the short term, this relationship will allow Nutritional High to secure additional revenue from its Pueblo facility, spread out the capital expenditures of the project in Nevada, and reduce product distribution costs. Over the long term, it is expected that the Lakeside relationship will ensure a consistent and high quality supply of trim, without the capital costs of growing.
Details of the Proposed Transaction
West Pueblo, Colorado
Nutritional High owns a property ("Property") with three buildings in Pueblo, Colorado which has been leased by Palo Verde, an arm's length entity which holds marijuana infused products license ("MIPs License"). Palo Verde currently uses Building 1 to manufacture adult use marijuana-infused products. Palo Verde had previously been granted a cultivation license ("OPC License") for Buildings 2 and a3, which have expired and are now in the process of being renewed. Nutritional High will lease to Lakeside Building 2 and other portions of the Pueblo Property where a greenhouse can be erected with the purposes of Lakeside building a cannabis cultivation facility for Palo Verde to operate once the OPC License is renewed.
Nutritional High will lease Building 2 to Lakeside at a rate of $15.00 per square foot of usable space per year payable monthly. The lease amount payable will accrue for up to 9 months during the time of the build out bearing an interest of 12% per annum. Lakeside will sublet the leased space to Palo Verde on a basis to be determined. Additional provisions will include:
It is expected that Palo Verde will sell the cannabis flower produced to various retailers, and will utilize the trim and shake it produces in the Lakeside Cultivation Facility in its oil extraction and edibles operation established with the assistance of Nutritional High. For greater clarity, neither Lakeside nor Nutritional High will own a cultivation or production license in the State of Colorado.
Nutritional High is considering applying for a marijuana production/processing license in Pennsylvania and has identified a property to acquire and service providers to assist on the application. If Nutritional High proceeds with this application, Lakeside will have the right to partner with Nutritional High on a similar basis to that being undertaken in Nevada.
Material and Related Party Interests in the Proposed Transaction
Nutritional High holds no interest in Lakeside. David Posner is a director of both Nutritional High and Lakeside beneficially owns 6,117,370 common shares in the capital of Nutritional High ("NH Shares") and 1,140,000 common shares in the capital of Lakeside ("Lakeside Shares"). Adam Szweras is a director of Nutritional High and is the Corporate Secretary of Lakeside and beneficially owns 1,161,701 Lakeside Shares and 1,134,227 NH Shares. FMI Capital Advisory Inc. ("FMICAI") acts as a financial advisor to both Nutritional High and Lakeside and owns 8,341,143 NH Shares and 1,071,075 Lakeside Shares. Peter Bilodeau, CEO and Director of Lakeside is also an executive officer of FMICAI and Adam Szweras is a chairman of FMICAI. No related parties or third parties own a controlling interest in Lakeside or Nutritional High. FMICAI is not receiving a finder's fee in connection with the Proposed Transaction.
Notwithstanding these relationships, the Proposed Transaction is considered to be an arm's length transaction, as Messrs, Szweras, Bilodeau and Posner have recused themselves from approval of the Proposed Transaction, and the Proposed Transaction was independently negotiated by special committees appointed by each of Lakeside and Nutritional High. On behalf of Nutritional High the Proposed Transaction was negotiated and approved by Robert Keeler, Brian Presement, David Caplan and headed by Jim Frazier, CEO of Nutritional High. On behalf of Lakeside the Proposed Transaction was negotiated and approved by Aurelio Useche and Hamish Sutherland, and headed by Robert Schwartz.
On completion of the Proposed Transaction, Nutritional High will own 1 million Lakeside Shares, representing approximately 3 percent of the issued and outstanding Lakeside Shares, or in the event the Lakeside Costs are not paid in a timely manner, Nutritional High will own 3 million Lakeside Shares, representing approximately 9 percent of the issued and outstanding Lakeside Shares.
As required, both of Lakeside and Nutritional High will be seek shareholder consent or approval of disinterested shareholders for the Proposed Transaction.
It is not contemplated that the board of Lakeside will change after completion of the Proposed Transaction, and will continue to be made up of Robert Schwartz, Hamish Sutherland, David Posner, Peter Bilodeau, Aurelio Useche (please see Lakeside press release dated December 22, 2016), and FMICAI will remain an insider in its capacity as financial advisor.
Lakeside wishes to advise that Yannis Banks has resigned as a director of Lakeside effective February 17, 2017. Lakeside expresses gratitude to Mr. Banks for his assistance and wishes him the best in his future endeavours.
Closing of the Proposed Transaction is subject to requisite shareholder and regulatory approval, including the approval of the TSX-V, successful completion of due diligence on the part of Lakeside, closing of financing in requisite amounts and other standard closing conditions.
Sponsorship of a Proposed Transaction may be required by the TSX-V unless exempt in accordance with TSX-V policies. Lakeside has not retained a Sponsor and intends to apply for an exemption from the sponsorship requirements. There is no assurance that Lakeside will ultimately obtain an exemption from sponsorship.
It is anticipated that the Proposed Transaction may be considered a Related Party Transaction under Policy 5.9 of the TSX Venture Exchange, which incorporate by reference Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions ("MI 61-101"). The Company believes that the Proposed Transaction is exempt from the requirement of having a formal valuation based on the exemption available under Section 5.5 (b) of MI 61-101 because the Lakeside Shares are not listed on the Toronto Stock Exchange and other exchanges enumerated therein. The Company believes that the Proposed Transaction is exempt from the requirement of minority approval based on the exemption available under Section 5.7 (1)(b) of MI 61-101 because the Proposed Transaction is a distribution of securities for cash for not more than $2,500,000. Neither Lakeside or Nutritional High has knowledge of any material information concerning Lakeside or Lakeside's Shares that has not been generally disclosed.
About Lakeside Minerals Inc.
Lakeside is currently a Mining Issuer pursuant to the policies of the TSXV, listed for trading on the NEX board. Management and board have considered potential strategies to maximize shareholder value in both the cannabis and mineral exploration sectors, including strategic alternatives relating to the Company's Launay project and different facets of the US cannabis industry with a specific focus on plant propagation and growing as retail segments of the value chain. With this new announcement, the Company will transition to a marijuana issuer, subject to necessary regulatory and shareholder approvals, with a focus on building grows that rely heavily on technology processes and data collection and analysis.
About Nutritional High International Inc.
Nutritional High is focused on developing, manufacturing and distributing products and nationally recognized brands in the hemp and marijuana-infused products industries, including edibles and oil extracts for nutritional, medical and adult recreational use. The Company works exclusively through licensed facilities in jurisdictions where such activity is permitted and regulated by state law.
For updates on Nutritional High's activities and highlights of the Company's press releases and other media coverage, please follow Nutritional High on Facebook, Twitter, Instagram and Google+ or visit www.nutritionalhigh.com.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR OTC MARKETS GROUP INC., NOR THEIR REGULATIONS SERVICES PROVIDERS HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
This news release may contain forward-looking statements and information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Such statements include submission of the relevant documentation within the required timeframe and to the satisfaction of the relevant regulators, completing the acquisition of the applicable real estate and raising sufficient financing to complete the Company's business strategy. There is no certainty that any of these events will occur. Although such statements are based on management's reasonable assumptions, there can be no assurance that such assumptions will prove to be correct. We assume no responsibility to update or revise them to reflect new events or circumstances.
Company's securities have not been registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), or applicable state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the United States or "U.S. Persons", as such term is defined in Regulation S under the U.S. Securities Act, absent registration or an applicable exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or any jurisdiction in which such offer, solicitation or sale would be unlawful.
Additionally, there are known and unknown risk factors which could cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained herein. All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law.
Completion of the transaction is subject to a number of conditions, including but not limited to, Exchange acceptance and if applicable, disinterested shareholder approval. Where applicable, the transaction cannot close until the required shareholder approval is obtained. There can be no assurance that the transaction will be completed as proposed or at all. Investors are cautioned that, except as disclosed in the management information circular or filing statement to be prepared in connection with the transaction, any information released or received with respect to the transaction may not be accurate or complete and should not be relied upon. Trading in the securities of Lakeside should be considered highly speculative. The TSX Venture Exchange Inc. has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this news release.Contacts: Lakeside Minerals Inc. Robert Schwartz Director 416-919-6980 Email: Nutritional High International Inc. David Posner Chairman of the Board 647-985-6727 Email: Greg Shafransky Investor Relations 360 Aviation Services Inc. 604-762-0969 Email: NEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...